Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Dr. Reddy's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500124
ISIN Demat	INE089A01031
Book Value	345.79

NSE Code	DRREDDY
Dividend Yield %	0.61
Market Cap	1101515.70

P/E	20.59
EPS	64.10
Face Value	1


	BSE		NSE

06-Jun-2025 14:33

Last Price	1319.55
Net Change	29.65
% Change	2.3%
Prev.Close	1289.90
Open	1301.80
High	1321.70
Low	1296.40
Volume	56213

Last Price	1319.90
Net Change	29.3
% Change	2.27%
Prev.Close	1290.60
Open	1295.10
High	1322.90
Low	1295.00
Volume	1617588

Value	74175864.15
Best Buy	1318.40
Best Sell	1319.05
Best Quantity	1
Sell Quantity	138
Today's Range	1321.70
52-Week High	1420.20
52-Week Low	1025.90

Value	2135054401.2
Best Buy	1319.70
Best Sell	1319.90
Best Quantity	2
Sell Quantity	106
Today's Range	1322.90
52-Week High	1421.49
52-Week Low	1020.00

Open Price	1303.50
High Price	1318.80
Low Price	1295.50
Last Price	1316.60
Prev Close	1292.40
Change	24.20
% Change	1.87 %

Average Price	1308.75
Underlying Value	1319.70
Number of contracts traded	3727
Turnover in Rs. Lakhs	30486
Open Interest	10465000.00
Change in O I	251250.00
% Change in O I	2.46 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	1
Price	1318.40

Quantity	138
Price	1319.05

Best Bid

Best Offer

Quantity	2
Price	1319.70

Quantity	106
Price	1319.90

Best Bid

Best Offer

Quantity	2500
Price	1316.2

Quantity	3750
Price	1316.7

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Aug-06

Book Closure

17-Jul-24

19-Jul-24

Dividend

800 %

10-Jul-25

Company News

05-06-2025

Dr. Reddy's Laboratories,...

05-06-2025

Dr. Reddy’s Laboratories...

05-06-2025

Dr. Reddy's Laboratories ...

26-05-2025

USFDA completes GMP inspe...

17-05-2025

USFDA completes GMP inspe...

17-05-2025

Dr Reddys Laboratories in...

10-05-2025

Dr. Reddy’s Laboratories ...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.